Trial · NCT06773364
Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial
NCT06773364, Phase 3, Recruiting, Shanghai East Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial. Trials, record NCT06773364. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06773364
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial
- NCT number
- NCT06773364
- Status
- Recruiting
- Phases
- Phase 3
- Enrollment
- 2,423 participants, estimated
- Lead sponsor
- Shanghai East Hospital
- Conditions
- Suspected Stroke
- Interventions
- Levetiracetam, Guide-recommended management, The lying flat (0°) head position, The sitting-up (≥30°) head position
- First posted
- 2025-01-14
- Last updated
- 2025-05-22
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Functional shift (improvement) in 7-level mRS scores | 90 days | |
| Secondary | neurological severity on the National Institute of Health stroke scale (NIHSS) | 24 hours from randomization | 0-42, higher scores indicates worse severity |
| Secondary | neurological severity on the National Institute of Health stroke scale (NIHSS) | 7 days | 0-42, higher scores indicates worse severity |
| Secondary | health related quality of life on the EQ-5D-5L | 90 days | |
| Secondary | severe disability (mRS 3-5) | 90 days | |
| Secondary | death and/or severe disability (mRS 3-6) | 90 days | |
| Secondary | utility-weighted-mRS (UW-mRS) | 90 days | |
| Secondary | proportion of hospital discharge at Day 7 | 7 days | |
| Secondary | living circumstances questions | 90 days | living at home \[the individual's own or that of a family member\] or living at an institution(hospital, care facility, or other) |
| Secondary | any seizures during follow-up | 90 days, 6 months, 12 months | assessed by 6 screening questions modified from the Canadian Longitudinal Study on Aging-Epilepsy Algorithm (CLSA-EA) |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06773364
GET https://conductscience.org/api/trials/v1/NCT06773364/registered